What's new

EMEA-002713-PIP02-21-M01

EMEA-002713-PIP02-21-M01

Feb 17, 2025 - 17:21
 0
EMEA-002713-PIP02-21-M01
EMEA-002713-PIP02-21-M01
Read More

Tags:

Previous Article

EMEA-002755-PIP01-19-M02

Next Article

Human medicines European public assessment report (EPAR): Daptomycin Hospira, da...

Related Posts

Infographic - Orphan Medicines in the EU

Feb 27, 2025  0

Human medicines European public assessment report (EPAR): Repaglinide Krka, repaglinide, Date of authorisation: 03/11/2009, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

Human medicines European public assessment report (EPAR): Spinraza, nusinersen, Date of authorisation: 30/05/2017, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0